Table 1: Demographic data, complications, comorbidity and ASA scores for non-frail and pre-frail/frail groups.
Variable | Non-frail Group | Pre-frail/Frail Group | p-value | CI | Effect Size |
Number, n (% of total) | 49 (49%) | 50 (51%) | - | - | - |
Male, n (% of the group) | 31 (63%) | 17 (34%) | < 0.01* | (-1.07) - (-0.24) | - |
Mean age, years (SD) | 60.82 (7.81) | 64.76 (9.17) | 0.02* | (-3.67) - (-0.27) | 0.23 |
Mean stature, cm (SD) | 173.18 (8.29) | 167.36 (10.32) | < 0.01* | (1.04) - (4.78) | 0.31 |
Mean body mass, kg (SD) | 82.38 (16.83) | 81.39 (19.35) | 0.79 | (-3.13) - (4.11) | 0.03 |
Mean BMI, kg/m2 (SD) | 27.49 (5.77) | 28.99 (6.00) | 0.21 | (-1.92) - (0.43) | 0.13 |
Adverse outcomes, n (SD)† | 0.72 (0.94) | 1.51 (1.72) | 0.01* | (-0.69) - (-0.08) | 0.30 |
Comorbidity Score, (0-35) (SD) | 3.07 (2.05) | 3.80 (2.37) | 0.11 | (-0.82) - (0.08) | 0.17 |
†p-value is adjusted with age; CI: confidence interval; SD: standard deviation; BMI: body mass index.